Atterocor Receives $16,000,000 Series A Financing Round

  • Feed Type
  • Date
    8/6/2012
  • Company Name
    Atterocor
  • Mailing Address
    820 Heatherway Ann Arbor, MI 48104
  • Company Description
    Atterocor is an innovative company focused on the accelerated development of a treatment for adrenal cancer. Founded in 2012 and backed by top-tier life sciences investors, Atterocor is based in Ann Arbor, Michigan.
  • Website
    http://www.atterocor.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $16,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Frazier Healthcare and 5AM Ventures led the round and proceeds from the financing will support Atterocor’s accelerated development of its lead program.
  • M&A Terms
  • Venture Investor
    Frazier Healthcare Ventures
  • Venture Investor
    5AM Ventures
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.